Entity Common Stock, Shares Outstanding of Regen BioPharma Inc from 01 May 2014 to 26 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Regen BioPharma Inc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 May 2014 to 26 Dec 2025.
  • Regen BioPharma Inc Entity Common Stock, Shares Outstanding for the quarter ending 26 Dec 2025 was 108,054,704.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 108,054,704 26 Dec 2025 10-K 30 Dec 2025 2025 FY
Q2 2025 31,554,704 +27,046,384 +600% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q3
Q2 2025 21,554,704 +17,046,384 +378% 21 May 2025 10-Q 28 May 2025 2025 Q2
Q1 2025 21,554,705 +17,440,083 +424% 30 Apr 2025 10-Q 16 May 2025 2025 Q1
Q2 2024 4,508,320 +1,126,954 +33% 17 Jul 2024 10-Q 13 Aug 2024 2024 Q3
Q1 2024 4,114,622 +733,256 +22% 31 Mar 2024 10-Q 24 Apr 2024 2024 Q2
Q4 2023 3,750,565 -5,044,679,705 -100% 31 Dec 2023 10-Q 19 Jan 2024 2024 Q1
Q3 2023 3,558,861 -5,027,958,463 -100% 06 Nov 2023 10-K 20 Nov 2023 2023 FY
Q2 2023 3,381,366 -4,966,621,466 -100% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q3
Q1 2023 3,381,366 -4,732,621,466 -100% 31 Mar 2023 10-Q 18 Apr 2023 2023 Q2
Q4 2022 5,048,430,270 +484,427,438 +11% 17 Jan 2023 10-Q 19 Jan 2023 2023 Q1
Q3 2022 5,031,517,324 28 Oct 2022 10-K 15 Nov 2022 2022 FY
Q2 2022 4,970,002,832 +406,000,000 +8.9% 17 Jul 2022 10-Q 22 Jul 2022 2022 Q3
Q1 2022 4,736,002,832 +989,579,044 +26% 07 Apr 2022 10-Q 21 Apr 2022 2022 Q2
Q4 2021 4,564,002,832 06 Dec 2021 10-K 22 Dec 2021 2021 FY
Q2 2021 4,564,002,832 30 Jun 2021 10-Q 20 Jan 2022 2022 Q1
Q1 2021 3,746,423,788 14 May 2021 10-Q 18 Aug 2021 2021 Q2
Q3 2019 571,484,406 26 Aug 2019 10-Q 24 Oct 2019 2019 Q3
Q4 2018 252,044,737 +105,863,938 +72% 31 Dec 2018 10-Q 12 Feb 2019 2019 Q1
Q2 2018 158,726,196 +21,759,499 +16% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q3
Q1 2018 151,327,211 +13,214,606 +9.6% 31 Mar 2018 10-Q 14 May 2018 2018 Q2
Q4 2017 146,180,799 +768,194 +0.53% 31 Dec 2017 10-Q 06 Feb 2018 2018 Q1
Q2 2017 136,966,697 +2,418,559 +1.8% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q3
Q1 2017 138,112,605 +9,858,667 +7.7% 31 Mar 2017 10-Q 05 May 2017 2017 Q2
Q4 2016 145,412,605 +21,125,333 +17% 31 Dec 2016 10-Q/A 28 Apr 2017 2017 Q1
Q3 2016 145,212,605 30 Sep 2016 10-K/A 28 Apr 2017 2016 FY
Q2 2016 134,548,138 +20,610,800 +18% 30 Jun 2016 10-Q/A 28 Apr 2017 2016 Q3
Q1 2016 128,253,938 +17,514,556 +16% 08 Apr 2016 10-Q/A 28 Apr 2017 2016 Q2
Q4 2015 124,287,272 +72,243,355 +139% 29 Dec 2015 10-K/A 28 Apr 2017 2015 FY
Q2 2015 113,937,338 +62,029,421 +119% 01 Jul 2015 10-Q/A 28 Apr 2017 2015 Q3
Q1 2015 110,739,382 +58,829,382 +113% 01 May 2015 10-Q/A 28 Apr 2017 2015 Q2
Q4 2014 52,043,917 09 Dec 2014 10-K 18 Dec 2014 2014 FY
Q2 2014 51,907,917 02 Aug 2014 10-Q 07 Aug 2014 2014 Q3
Q1 2014 51,910,000 01 May 2014 10-Q 05 May 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.